Borralleras C, Castrodeza J, Arrazola P, Cámara-Hijón C, Eiros JM, Fernández M, et al. 
 

Vaccination against SARS-CoV-2 is essential to mitigate the personal, social and global impact of the coronavirus disease (COVID-19) as we move from a pandemic to an endemic phase. Vaccines are now required that offer broad, long-lasting immunological protection from infection in addition to protection from severe illness and hospitalisation. Here we present a review of the evidence base for a new COVID-19 vaccine, PHH-1V (BIMERVAX®, HIPRA), and the results of an expert consensus.